[Clinical validation of screening scales for late onset of hypogonadism in Chinese males].

Shan-Jie Zhou, Wen-Hong Lu, Dong Yuan, Li Hong, Ru-Ming Shu, Di Guan, Yi‐Qun GuPubMed 2010

Abstract

The sensitivity and specificity of ADAM and AMS in the Chinese population are basically consistent with the results of most studies abroad, while the positive rate of LOH screening, the rate of androgen deficiency and the clinical incidence of LOH obviously higher in the former than those reported in other studies. Both ADAM and AMS are applicable to the Chinese population. The former is advantageous for its high sensitivity, time saving and easy operation, and therefore suitable for screening LOH, while the latter can be used for monitoring therapeutic efficacy.
BibTeX
@inproceedings{zhou2010clinical,
  author = {Shan-Jie Zhou and Wen-Hong Lu and Dong Yuan and Li Hong and Ru-Ming Shu and Di Guan and Yi‐Qun Gu},
  title = {{[Clinical validation of screening scales for late onset of hypogonadism in Chinese males].}},
  booktitle = {PubMed},
  year = {2010},
}

Loading related content...

Figure